Translational Development Acquisition Corp. to acquire Prologium Holding Inc.

Translational Development Acquisition Corp. and Prologium Holding Inc. have agreed to merge in a transaction structured as a merger of equals. The two entities, both incorporated in the Cayman Islands, are combining their operations within the technology sector. The deal was announced on 27 July 2026, marking a significant step for both organisations as they seek to consolidate their market positions. The consideration for this combination will be made entirely through the issuance of shares, rather than cash or other assets. This equity-based structure suggests a focus on long-term alignment between the shareholders of the merging parties. No specific financial value has been disclosed for the transaction, and the exact exchange ratio remains undefined at this stage. The parties have not provided detailed projections regarding the combined entity’s future revenue or earnings potential.

The transaction is currently at the firm intention stage, indicating that both boards have formally agreed to proceed with the merger. However, the deal has not yet been completed, and no closing date has been set. Regulatory approvals and shareholder consent will likely be required before the merger can be finalised. Both companies will continue to operate independently until the transaction is fully executed. The combined entity will retain the technology focus of its predecessors, aiming to leverage synergies in the broader tech landscape. Further details on the governance structure and leadership roles in the merged company have not been released. The transaction is subject to regulatory approval.